InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,280.40
(
0.34%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.34
(
1.02%
)
Bitcoin
61,428.07
(
1.01%
)
Post# of 1509
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

l2 hunter

Send PM Follow Ignore
Followers 4834
Posts 168857
Boards Moderated 1
Alias Born 02/21/2011

l2 hunter

Re: l2 hunter post# 1267

Tuesday, 11/27/2018 3:37:59 PM

Tuesday, November 27, 2018 3:37:59 PM

Post# of 1509
What's Next
The deal is expected to close in the first quarter of 2019.

Following the consummation of the deal, the merged entity will function under the name PDS Biotechnology Corp., with the shares of the combined company to be listed on the Nasdaq under a new ticker symbol to be announced at a later date.

On the pipeline front, the combined company plans to initiate Phase 2b/3 clinical trials of PDS101 in HPV-associated cancers




http://investorshub.advfn.com/boards/board.aspx?board_id=20962

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up